Comment
doi: 10.1001/archinternmed.2012.1827.
Atypical femoral fracture risk in patients treated with bisphosphonates
Affiliations
- PMID: 22732750
- PMCID: PMC4014073
- DOI: 10.1001/archinternmed.2012.1827
Item in Clipboard
Comment
Atypical femoral fracture risk in patients treated with bisphosphonates
Arch Intern Med.
.
No abstract available
Comment on
-
Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.Arch Intern Med. 2012 Jun 25;172(12):930-6. doi: 10.1001/archinternmed.2012.1796. Arch Intern Med. 2012. PMID: 22732749
Similar articles
-
Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!Acta Orthop. 2012 Aug;83(4):319-20. doi: 10.3109/17453674.2012.718517. Epub 2012 Aug 20. Acta Orthop. 2012. PMID: 22900912 Free PMC article. No abstract available.
-
Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection.J Bone Joint Surg Am. 2013 Jan 16;95(2):e8 1-13. doi: 10.2106/JBJS.L.00568. J Bone Joint Surg Am. 2013. PMID: 23324969 Review. No abstract available.
-
Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.Arch Intern Med. 2012 Jun 25;172(12):930-6. doi: 10.1001/archinternmed.2012.1796. Arch Intern Med. 2012. PMID: 22732749
-
Atypical femur fractures associated with use of bisphosphonates and denosumab.Ann Oncol. 2015 Apr;26(4):819-820. doi: 10.1093/annonc/mdv014. Epub 2015 Jan 20. Ann Oncol. 2015. PMID: 25605743 No abstract available.
-
Questioning the association between bisphosphonates and atypical femoral fractures.Ann N Y Acad Sci. 2015 Jan;1335(1):1-9. doi: 10.1111/nyas.12551. Epub 2014 Oct 7. Ann N Y Acad Sci. 2015. PMID: 25294742 Free PMC article. Review.
Cited by
-
Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing.J Clin Med. 2022 Dec 16;11(24):7477. doi: 10.3390/jcm11247477. J Clin Med. 2022. PMID: 36556093 Free PMC article. Review.
-
Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.Osteoporos Int. 2019 Nov;30(11):2349-2354. doi: 10.1007/s00198-019-05131-2. Epub 2019 Aug 19. Osteoporos Int. 2019. PMID: 31428823
-
Successful conservative treatment: multiple atypical fractures in osteoporotic patients after bisphosphate medication: a unique case report.Medicine (Baltimore). 2015 Feb;94(5):e446. doi: 10.1097/MD.0000000000000446. Medicine (Baltimore). 2015. PMID: 25654380 Free PMC article.
-
Histology of 8 atypical femoral fractures: remodeling but no healing.Acta Orthop. 2014 Jun;85(3):280-6. doi: 10.3109/17453674.2014.916488. Epub 2014 Apr 30. Acta Orthop. 2014. PMID: 24786905 Free PMC article.
-
Atypical femoral fractures associated with long-term bisphosphonate use.CMAJ. 2013 Oct 1;185(14):1248. doi: 10.1503/cmaj.121698. Epub 2013 May 6. CMAJ. 2013. PMID: 23649415 Free PMC article. No abstract available.
References
-
- Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90(3):1294–1301. - PubMed
-
- Goh SK, Yang KY, Koh JS, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007;89(3):349–353. - PubMed
-
- Shane E, Burr D, Ebeling PR, et al. American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25(11):2267–2294. - PubMed
-
- Black DM, Kelly MP, Genant HK, et al. Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362(19):1761–1771. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
